AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 1 filers reported holding AXOVANT GENE THERAPIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $809,000 | – | 175,158 | +8757800.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 2 | -100.0% | 0.00% | – |
| Q1 2020 | $53,000 | +657.1% | 21,698 | +1392.3% | 0.00% | – |
| Q4 2019 | $7,000 | -97.8% | 1,454 | -97.0% | 0.00% | – |
| Q3 2019 | $314,000 | +6.8% | 48,650 | +3.0% | 0.00% | – |
| Q2 2019 | $294,000 | – | 47,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|